Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562/A02 cells via multiple mechanisms - 03/08/11
, Beibei Qu, Yongfeng Zhang, Ning Ma, Qingkun Han
Corresponding author. Tel.: +0086 431 88782180, Tel.: +0086-139 43001600; fax: +0086 431 88786120.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 5 |
| Iconographies | 4 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
The present study aimed to study the mechanisms by which low dose arsenic trioxide (As2O3) reduces multidrug resistance. The potential influence of As2O3 on cytotoxicity was examined by methyl thiazolyl tetrazolium (MTT) assay and the intracellular mean fluorescence intensity (MFI) of Adriamycin (ADM) was examined by flow cytometry. The gene expression of mdr1 mRNA was determined by RT-PCR. The change of cellular expression levels of drug resistant-related proteins, including P-gp, bcl-2, Topo-II, and GST-π, were measured by Western-blotting or immunocytochemistry assay. Data showed As2O3 at non-cytotoxic concentration (2μM) significantly increased the cytotoxicity of ADM on K562/A02 cells. Cotreatment of As2O3 and ADM significantly increased the ADM MFI than ADM alone (P<0.01). Following pretreatment of K562/A02 cells with As2O3, the expression of Topo-II was increased while the expression of GST-π and bcl-2 was decreased. No obvious alternation of expression of mdr1 mRNA or P-gp was observed. Thus, low dose As2O3 partially reduced drug resistance to ADM in K562/A02 cells via multiple mechanisms, which selectively inhibited the efflux pump GST-π but not P-gp, as well as modulated the expression of MDR-related proteins such as Topo-II and bcl-2, in line with previous studies. In conclusions: The effect of As2O3 on reducing MDR may have wide clinical application in chemotherapy regimens for leukemia.
Le texte complet de cet article est disponible en PDF.Keywords : Arsenic trioxide, K562/A02, GST-π, P-gp, MDR
Plan
Vol 65 - N° 5
P. 354-358 - août 2011 Retour au numéro
Article précédent
- The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines
- Ana Podolski-Renić, Tijana Anđelković, Jasna Banković, Nikola Tanić, Sabera Ruždijić, Milica Pešić
- A three-dimensional morphological reconstruction of uterine leiomyoma pseudocapsule vasculature by the Allen-Cahn mathematical model
- Antonio Malvasi, Andrea Tinelli, Siavash Rahimi, Giampaolo D’Agnese, Cristiana Rotoni, Domenico Dell’Edera, Daniel A. Tsin, Carlo Cavallotti
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?